Navigation Links
London Genetics Conference Proceedings Published in Drug Discovery Today
Date:5/12/2010

LONDON, May 12, 2010 /PRNewswire/ -- London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, is pleased to announce that the importance of this approach is being highlighted with the publication of its inaugural conference [1] proceedings in the May 2010 issue of Drug Discovery Today. The conference, 'Harnessing Genetic Knowledge To Improve Clinical Development and Patient Care'[2], brought together pharma and biotech companies, academia and regulatory bodies to discuss the value that pharmacogenetics can bring to drug development.

Recognising that pharmacogenetics is a key part of the mission to get the right drug to the right patient at the right dose, delegates discussed how to integrate it more fully into drug development. Issues debated ranged from the role of pharmacogenetics in cost-effectiveness studies, possible changes in the way clinical trials are performed, and the need for sophisticated bioinformatics to capture and analyse data. One of the conclusions reached was that early collaboration between academia, industry, the regulatory authorities, and those that foot the healthcare bill was pivotal for capturing the maximum potential from pharmacogenetics.

Dominique Kleyn, CEO of London Genetics, said 'Drug Discovery Today is recognised as being at the cutting edge of new developments underlying R&D in the pharma and biotech industry. Publication of our article provides a strong validation of the potential of pharmacogenetics, and the importance of the issues raised at London Genetics' inaugural conference. We look forward to discussing progress in the field at our second pharmacogenetics conference, to be held in November 2010 in

SOURCE London Genetics Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. First Awards Made by London Genetics Proof-of-Concept Fund
2. Expanded London Genetics Web Site Emphasises Importance of Pharmacogenetics in Drug Development
3. Hologic to Present at NASDAQ OMX 23rd Investor Program in London
4. London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference
5. PRA International: Participating Sponsor for Exploratory Clinical Development World in London
6. Interleukin Genetics, Inc. Announces Conference Call to Discuss First Quarter 2010 Results
7. NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards
8. Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
9. Interleukin Genetics to Raise $5.3 Million in Registered Direct Offering
10. Viral Genetics CEO Issues State of the Company Update
11. Ambry Genetics Announces Launch of Their StemArray(TM) Product and Services for High Resolution Characterization of Human Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... DALLAS , Aug. 27, 2014 /PRNewswire-iReach/ -- "Fatty ... data on the Fatty Liver Disease clinical trial scenario. ... the clinical trials on Fatty Liver Disease . ... their recruitment status as per the site of trial ... coverage of disease clinical trials by their phase, trial ...
(Date:8/27/2014)... -- Ambit Biosciences (Nasdaq: AMBI ), a biopharmaceutical company ... in oncology, autoimmune and inflammatory disease, today announced the Company,s ... held at The New York Palace Hotel in ... Alan Fuhrman , Ambit,s CFO, will provide an ... at 1:10 p.m. ET on Wednesday, September 3, 2014.  The ...
(Date:8/27/2014)... REDWOOD CITY, Calif. , Aug. 27, 2014 ... in emergency response system design, blended emergency medical ... for CPR/AED (automated external defibrillator) training from the ... and the Army Reserve 81 st ... Homeland Security and Investigations contract includes nationwide CPR/AED/First ...
Breaking Medicine Technology:Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 2Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 3Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 4Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 5Ambit Announces Participation At Baird 2014 Health Care Conference 2Emergency University Equips Homeland Security, Army Reserve with SCA Response Program to Save Lives of Sudden Cardiac Arrest Victims 2Emergency University Equips Homeland Security, Army Reserve with SCA Response Program to Save Lives of Sudden Cardiac Arrest Victims 3
... March 1, 2011 Heska Corporation (Nasdaq: ... and specialty products to veterinarians, today announced the addition ... in-clinic blood analyzers. (Logo:   http://photos.prnewswire.com/prnh/20000622/HESKALOGO ) ... analyzer is used to measure lactate, and is ideal ...
... successful contract packaging and re-packaging companies in the ... new, single-source industry leader called Aphena Pharma ... corporation based on a strategic alliance between Celeste ... Packaging; all long-term specialized leaders in the contract ...
Cached Medicine Technology:Heska Introduces New Lactate Meter Analyzer 2Merger of Four Pharmaceutical Companies Announced 2
(Date:8/27/2014)... Overcoming a turbulent past which branded KC Armstrong ... Women’s Radio Network, WRNW1, has recently signed a multi-million dollar ... to the WRNW1 family. KC states, “it is such a ... atmosphere.” After KC Armstrong publicly announced his appreciation to Howard ... show, “Howard 100 News,” have decided to pay it forward. ...
(Date:8/27/2014)... IntelliSoft Group, LLC, a leading provider of ... IntelliCred, IntelliApp and IntelliContract Version 14.2 ... (NHAMSS) Annual Conference on September 16, 2014 at the ... Notable improvements available in IntelliSoft’s Version 14.2 ... Linking: A new Contract Connection Tab connects the healthcare ...
(Date:8/27/2014)... Time to Play Golf, a fast-growing golf ... , With 80-degree temperatures and only partially clouded skies, the ... Inaugural Outing. Around 50 golfers showed up to duel it ... Heron Glen Golf Course in Ringoes, New Jersey. , The ... be having a great time. Birdies were dropping and those ...
(Date:8/27/2014)... Los Angeles, California (PRWEB) August 27, 2014 ... unveiled its “Journey Candle Collection” to provide a growing number ... executives a scent-based tool for goal setting and relaxing at ... of six soy candles, uses scent memory and visualization to ... milestone in their life each time they light a candle ...
(Date:8/27/2014)... 2014 Michael A. Bottar ... of The Best Lawyers In America© for the practice ... Injury Litigation - Plaintiffs." , Bottar received his undergraduate ... laude graduate of Syracuse University College of Law where ... Practice" chapter of the Syracuse Law Review Survey of ...
Breaking Medicine News(10 mins):Health News:The Women's Radio Network, WRNW1, Signs KC Armstrong to a Multi-Million Dollar Contract 2Health News:IntelliSoft Group to Unveil Version 14.2 of IntelliCred, IntelliApp and IntelliContract at the New Hampshire Association of Medical Staff Services Annual Conference 2Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:In My Solitude Unveils Eco Candle Line That May Improve Performance 2Health News:Michael A. Bottar Selected For Inclusion In The Best Lawyers In America© 2015 2
... 25 WellPoint, Inc. (NYSE:,WLP) announced today that ... Healthcare Conference on January 30, 2008. The presentation ... Time., All interested parties are invited to ... http://www.wellpoint.com and selecting the "Investor,Info" link. ...
... 25, 2008 Researchers from Mayo Clinic in ... stents (SEPSs) in the treatment of benign esophageal disease ... stent migration and few cases of long-term improvement. They ... patient populations and to guide future recommendations for the ...
... must pass more than lip service reform in wake ... The following is a,statement by Executive Director, Kurt Entsminger, ... are among the most restrictive,in the nation. To get ... by the symptoms of an illness like,schizophrenia to be ...
... Bill Novelli,made the following statement about next Monday,s vote on ... by the California State Senate,Committee on Health:, "On behalf ... the members of the State Senate Health Committee to pass ... Monday. ABX 1 1 represents a major step toward,ensuring that ...
... Inc. ("Assurant"),(NYSE: AIZ ), a premier provider of ... its board of,directors has declared a quarterly dividend of ... March 10, 2008 to shareholders of record as of,Feb. ... at the discretion of the,board of directors and will ...
... 25, 2008 --New York, NY-- Researchers in Belgium have ... with the capacity to generate new insulin-producing beta cells. ... the newfound progenitor cells may represent an obvious target ... researchers report in the Jan. 25 issue of the ...
Cached Medicine News:Health News:WellPoint Announces Appearance at Upcoming Conference 2Health News:Study examines self-expanding plastic stents in the treatment of benign esophageal conditions 2Health News:Study examines self-expanding plastic stents in the treatment of benign esophageal conditions 3Health News:Virginia Must Prize Mental Illness Treatment Over Psychosis 2Health News:Virginia Must Prize Mental Illness Treatment Over Psychosis 3Health News:Elusive pancreatic progenitor cells found in mice 2
... The Bio-Optics LSM-12000 is a new ... powerful new tool in anterior segment diagnostics ... easy to operate, easy to maintain, and ... is the only High Magnification Slit-Lamp Biomicroscope ...
70 discs to investigate acquired color deficiency. Quantifies neutral zone characteristics of dyschromatopsia and evaluates the relative luminance....
... a rapid field or laboratory test for the ... simple, two-step test provides results in 10 minutes, ... , ,Intended use: The NOW® Hepatitis B sAg/eAg ... the detection of Hepatitis B surface antigen (HBsAg) ...
... the newest technology available in acrylic lens ... exceptional material and design properties to achieve ... , Unique foldable hydrophobic acrylic material ... biostable , High index of refraction ...
Medicine Products: